The Role of CCR9 and Melanoma Metastasis to Small Intestine. Farin Amersi, MD Samuel Oschin Comprehensive Cancer Center Cedar Sinai Medical Center

Similar documents
Functional CCR9 Expression Is Associated with Small Intestinal Metastasis

IMPC phenotyping SOPs in JMC

(A) RT-PCR for components of the Shh/Gli pathway in normal fetus cell (MRC-5) and a

Characteristics, treatment patterns, and survival outcomes of primary GI melanoma cases compared to cutaneous melanoma, SEER:

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

came from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

category cm0. Category will ensure it T1 melanoma. 68 Retinoblastoma

Gastric Cancer Histopathology Reporting Proforma

Melanoma gene expression profiles to identify mechanisms of tumor resistance

AJCC 7th Edition Handbook Errata as of 9/21/10

Supplemental materials

Carcinoembryonic Antigen

Commonly Encountered Neuro-Endocrine Tumors of the Gut

DIVISION OF GASTROENTEROLOGY

Wendy L Frankel. Chair and Distinguished Professor

CASE DISCUSSION ON GASTRIC CANCER BASED ON ESMO GUIDELINES

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

Histological and immunological characteristics of colitis associated with anti-ctla 4 antibody therapy

Surgical Issues in Melanoma

Macmillan Publications

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Pancreatic Adenocarcinoma: What`s hot

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.

Gastroenterology Tutorial

Liver Cancer. Su Jong Yu, M.D. Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine

COLORECTAL CANCER CASES

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Surgical Management of Neuroendocrine Tumors of the Gut. Richard Hodin MD Professor of Surgery Massachusetts General Hospital Harvard Medical School

T of patients with malignant melanoma

Metastatic Colorectal Cancer

Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

SMALL BOWEL ADENOCARCINOMA. Dr. C. Jeske

Surgical Therapy of GEP-NET: An Overview

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Species Tumor Type Comment for in vivo work Lead Time for in vivo studies [weeks] MB-49-luc-2 Mouse urinary bladder carcinoma C57BL/6 2

Endoscopic Ultrasonography Assessment for Ampullary and Bile Duct Malignancy

Images In Gastroenterology

OFCCR CLINICAL DIAGNOSIS AND TREATMENT FORM

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Birthday: 1952/07/31 Date of admission:1999/12/30 Age:48 y/o Past medication:esrd under regular HD for 5+ years; denied DM and HTN

Adenocarcinoma of gastro-esophageal junction - Case report

NET und NEC. Endoscopic and oncologic therapy

Metastatic Colorectal Cancer

A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY

Histopathology of Endoscopic Resection Specimens from Barrett's Esophagus

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

CODING STAGE: TNM AND OTHER STAGING SYSTEMS. Liesbet Van Eycken Otto Visser

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology

Earlyoesophagealcancer. dr. Nina Zidar Institute of Pathology Faculty ofmedicine University of Ljubljana Slovenia

Latest Press Release. woman roasted over fireoman roasted

The Immune System: The Mind Body Connection. Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco

SAM PROVIDER TOOLKIT

Registrar s Guide to Chapter 1, AJCC Seventh Edition. Overview. Learning Objectives. Describe intent and purpose of AJCC staging

CS 6824: Tissue-Based Map of the Human Proteome

Anaplastic A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

Imaging in gastric cancer

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Greater Manchester & Cheshire Guidelines for Pathology Reporting of Oesophageal and Gastric Malignancy

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Definition of Synoptic Reporting

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

GASTROINTESTINAL METASTASES FROM LOBULAR BREAST CANCER

Multiorgan Resection (Including the Pancreas) for Metastasis of Cutaneous Malignant Melanoma

Imaging of Neuroendocrine Metastases

The Lymphoid System Pearson Education, Inc.

Study of expression of P53 in Gastric Carcinoma As a prognostic indicator

Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

Comprehensive cancer cover

ANGPTL2 increases bone metastasis of breast cancer cells through. Tetsuro Masuda, Motoyoshi Endo, Yutaka Yamamoto, Haruki Odagiri, Tsuyoshi

Unexpected Findings at Endoscopy

Targeting tumour associated macrophages in anti-cancer therapies. Annamaria Gal Seminar Series on Drug Discovery Budapest 5 January 2018

Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori

Gastrinoma: Medical Management. Haley Gallup

1.The metastatic cascade. 2.Pathologic features of metastasis. 3.Therapeutic ramifications

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Comprehensive cancer cover

CLINICAL EFFECTIVENESS

Peritoneal Involvement in Stage II Colon Cancer

Oncology General Principles L A U R I E S I M A R D B R E A S T S U R G I C A L O N C O L O G Y F E L L O W D E C E M B E R

Stage 4 gastric adenocarcinoma icd 10

CD4+ T Helper T Cells, and their Cytokines in Immune Defense and Disease

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

SCOPE OF PRACTICE PGY-5

Validation of QClamp as Next Generation Liquid Biopsy Technique for Colorectal Cancer He James Zhu M.D. Ph.D

Corporate Medical Policy

An epithelial-to-mesenchymal transition-inducing potential of. granulocyte macrophage colony-stimulating factor in colon. cancer

1. The metastatic cascade. 3. Pathologic features of metastasis. 4. Therapeutic ramifications. Which malignant cells will metastasize?

SUPPLEMENTARY INFORMATION

Animal Models to Understand Immunity

2014 International Journal of Medical Science Research and Practice available on

Neuroendocrine Tumors

Clinicopathologic Spectrum of Gastrointestinal Stromal Tumours; Six Years Experience at King Hussein Medical Center

COLORECTAL CARCINOMA

Modulation of upa, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines

Transcription:

The Role of CCR9 and Melanoma Metastasis to Small Intestine Farin Amersi, MD Samuel Oschin Comprehensive Cancer Center Cedar Sinai Medical Center

BACKGROUND Melanoma is the fifth most common cancer. Estimated that 67,190 cases (5% cancer cases) will be diagnosed this year. (Am. Cancer Soc, 2007) Postmortem specimens 50-60% metastases to GI tract

BACKGROUND Melanoma metastatic to GI tract in only 1.5 7.9% of all pts 1/3 of all metastatic disease of the GI tract is from melanoma Postmortem specimens 50-60% metastases to GI tract

CHEMOKINES -RECEPTORS

Chemokines and their receptors determine the metastatic destination of tumor cells. Final distribution of metastases reflects relative abundance of chemokines in different organs Neutralizing the interaction of chemokines and their receptors impairs metastasis of cancer cells

THE MECHANISM DETERMINING THE DIRECTIONAL MIGRATION AND INVASION OF MELANOMA CELLS INTO SPECIFIC ORGANS IN THE GASTROINTESTINAL TRACT NEEDS TO BE ESTABLISHED

OVERVIEW BACKGROUND HYPOTHESIS METHODS RESULTS PLANNED STUDIES

TECK / CCL25 Thymus expressed chemokine (TECK) initially reported to be expressed by thymic cells TECK expression recently localized to epithelium of small intestine but not colon or stomach CCR9 is the only known receptor for TECK; expressed at high levels by CD4+ and CD8+ lymphocytes in small bowel

Zabel et al, JEM 1999, 190(9):1241-1256

The Role of Thymus-Expressed Chemokine and its Receptor CCR9 on Lymphocytes in the Regional Specialization of the Mucosal Immune System K. Papadakis,, J. Prehn,, V. Nelson, A. Cheng, S.W. Binder, P.D. Ponath,, D.P. Andrew, and S.T. Targan Journal of Immunology, 2000; 165(9): 5069-76.

CCR9 and Immune Diseases In PBL, CCR9+ lymphocytes markedly elevated in small bowel Crohn s,, but not in pure colonic Crohn s TECK expression intensely expressed in small bowel but was not expressed in either normal or inflamed colon. Gastroenterology, 2001; 121:246-254

QUESTIONS Is CCR9 expressed in melanoma cell lines generated from metastases to the small intestine Are there differences in CCR9 expression in melanoma cell lines derived from small intestinal metastases when compared to cell lines derived from metastases to other GI organs

QUESTIONS If CCR9 is expressed only in melanoma cell lines derived from small intestinal metastases, will these findings correlate with our analysis using paraffin embedded tissue. Is CCR9 expressed in the primary or regional lymph nodes

QUESTIONS If CCR9 is expressed only in small intestinal metastases, will these findings correlate with overall survival If CCR9 is expressed in the primary tumor or lymph nodes, can it be utilized as a prognostic indicator for future metastatic progression

HYPOTHESIS CCR9 is expressed in melanoma cell lines derived from small bowel Melanoma cells that express CCR9 functionally, respond to TECK in a manner that facilitates metastases of these cells from the primary site or lymph nodes to small bowel

METHODS: CELL LINES RNA extraction Reverse transcription Real Time PCR Cell migration/invasion assay

CELL LINES Eight cell lines from melanoma metastasis to small bowel from JWCI tissue repository Fifteen cell lines from melanoma metastasis to other distant organs Liver- 4 Pancreas-1 Lung- 3 Adrenal- 2 Kidney- 2 Colon- 2 Gastric- 1

RESULTS CCR9 expressed in 8/8 (100%) small bowel cell lines CCR9 not expressed in 15/15 metastatic cell lines to other distant organs

CCR9/GAPDH mrna 5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 CCR9 Expression FL UK PC DM MG HC MP SJ MOLT4 SMALL BOWEL MELANOMA CELL LINES

CCR9 Expression CCR9/GAPDH mrna 5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 liver adrenal colon kidney pancreas stomach small bowel Cell lines lung MOLT

Further Studies Complete analysis of paraffin specimens from small bowel metastasis/distant organs Validate CCR9 Expression by flow cytometry TECK expression in paraffin tissue from small bowel metastasis/distant organs Immunohistochemistry Migration/Invasion Assay in SB cell lines

METHODS PARAFFIN EMBEDDED TISSSUE 198 STAGE 4 MELANOMA PATIENTS - 102 Small bowel resections - 96 Surgical resection to other distant sites 23 STAGE 1 PRIMARY MELANOMA PATIENTS - 7 matched pairs to stage IV pts with small bowel metastasis - 16 stage 1 primary